# Processa Pharmaceuticals, Inc.: Form 8-K, filed Jul 25, 2022

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2022-07-25
- Accepted by EDGAR: Jul 25, 2022, 16:48 ET
- Period: 2022-07-19
- Accession: 0001493152-22-020258
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/form8-k.htm

Filed Jul 25, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-020258. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
